AlphaFold predicted structure
ARHGEF40 · Q8TER5

Mean pLDDT
63.0/ 100
Low
1,519 residues
Confidence breakdown
- Very high(≥ 90)16%
- Confident(70–90)39%
- Low(50–70)6%
- Very low(< 50)40%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
Rho guanine nucleotide exchange factor 40
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Fetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownAbnormality of the skeletal system
neurodegenerative disease
neuroblastoma
atrial fibrillation
aortic valve disorder
Global developmental delay
myoepithelial tumor
Familial prostate cancer
prostate cancer
retinitis pigmentosa
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Rho guanine nucleotide exchange factor 40
Acts as a guanine nucleotide exchange factor (GEF) for RHOA and RHOC (PubMed:15107133, PubMed:26823019). Promotes actin stress fiber formation, force-induced stress fiber reinforcement and organization of KRT8/KRT18 networks via activation of RHOA/ROCK signaling, which is mediated by N-terminus KRT18 binding (PubMed:26823019, PubMed:30929300). Regulates the formation or maintenance of properly elongated morphology of epithelial tubules, via mediation of the organization and orientation of KRT18 filaments (By similarity). Promotes RHOA-dependent, cell-cell contact mediated reorientation of endothelial cells and their actin stress fibers in response to mechanotransduction (PubMed:25795300). Positively regulates hemidesmosome formation via acting as a linker protein that anchors keratin filaments to hemidesmosomes (PubMed:29672603). Also required for JUP localization at cell-cell adhesion junctions (PubMed:26823019)
ARHGEF40 · Q8TER5

Mean pLDDT
63.0/ 100
Low
1,519 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0